Table of Contents  by unknown
Volume 17, Number 8, August 2011
REVIEW
1099 Relapsing Hematologic Malignancies after Haploidentical
Hematopoietic Stem Cell Transplantation
Yong-Xian Hu, Qu Cui, Bin Liang, He HuangEDITORIAL
1112 Ex Vivo T Cell Depletion of Allogeneic PBSC as Acute and Chronic
GVHD Prophylaxis after Myeloablative HCT: Time to Reconsider?
Vincent T. HoCOMMENTARY
1114 Rationale and Design of the Chronic GVHD Cohort Study: Improving
Outcomes Assessment in Chronic GVHD
The Chronic GVHD ConsortiumBIOLOGY
1121 Activation and Expansion of CD81 T Effector Cells in Patients with
Chronic Graft-versus-Host Disease
Bryan M. Grogan, Laura Tabellini, Barry Storer, Tara E. Bumgarner,
Claudia C. Astigarraga, Mary E. D. Flowers, Stephanie J. Lee, Paul J. Martin,
Edus H. Warren, John A. Hansen1133 Immunosuppressive Effects of Multiple Myeloma Are Overcome
by PD-L1 Blockade
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D. JohnsonCLINICAL RESEARCH
1146 Transplanted CD34
1 Cell Dose Is Associated with Long-Term PlateletCount Recovery following Autologous Peripheral Blood Stem Cell
Transplant in Patients with Non-Hodgkin Lymphoma
or Multiple Myeloma
Patrick J. Stiff, Ivana Micallef, Auayporn P. Nademanee, Edward A. Stadtmauer,
Richard T. Maziarz, Brian J. Bolwell, Gary Bridger, Sachin Marulkar, Frank J. Hsu,
John F. DiPersio1154 Pharmacologic Expansion of Donor-Derived, Naturally Occurring
CD41Foxp31 Regulatory T Cells Reduces Acute Graft-versus-Host
Disease Lethality Without Abrogating the Graft-versus-Leukemia
Effect in Murine Models
Omar Duramad, Amy Laysang, Jun Li, Yasuyuki Ishii, Reiko Namikawa1169 Lymphocyte Recovery Predicts Outcomes in Cord Blood and
T Cell–Depleted Haploidentical Stem Cell Transplantation
Stefan O. Ciurea, Victor Mulanovich, Ying Jiang, Roland Bassett, Gabriela Rondon,
John McMannis, Marcos de Lima, Elizabeth J. Shpall, Richard E. ChamplinContinued
Contents, continued1176 Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus
BK Virus–Associated Hemorrhagic Cystitis in Allogeneic
Hematopoietic Stem Cell Transplantation Recipients
Ashley N. Miller, Ashley Glode, Kathy R. Hogan, Christine Schaub, Cindy Kramer,
Robert K. Stuart, Luciano J. Costa1182 Retrospective Outcome Data for Hematopoietic Stem Cell
Transplantation in Patients with Concurrent Coronary
Artery Disease
Elizabeth E. Stillwell, Jeffrey D. Wessler, Brian J. Rebolledo, Richard M. Steingart,
Erica L. Petrlik, Ann A. Jakubowski, Wendy L. Schaffer1187 Allogeneic Hematopoietic Cell Transplantation with Full-Intensity
Conditioning for Adult Acute Lymphoblastic Leukemia: Results from
a Single Center, 1998-2006
Kristine Doney, Ted A. Gooley, H. Joachim Deeg, Mary E. D. Flowers, Rainer Storb,
Frederick R. Appelbaum1196 Use of Matched Unrelated Donors Compared with Matched
Related Donors Is Associated with Lower Relapse and Superior
Progression-Free Survival after Reduced-Intensity Conditioning
Hematopoietic Stem Cell Transplantation
Vincent T. Ho, Haesook T. Kim, Julie Aldridge, Deborah Liney, Grace Kao,
Philippe Armand, John Koreth, Corey Cutler, Jerome Ritz, Joseph H. Antin,
Robert J. Soiffer, Edwin P. Alyea1205 The Outcomes of Family Haploidentical Hematopoietic Stem Cell
Transplantation in Hematologic Malignancies Are Not Associated
with Patient Age
Lujia Dong, Tong Wu, Zhi-Yong Gao, Mei-Jie Zhang, Fangyu Kan,
Stephen R. Spellman, Xi-You Tan, Yan-Li Zhao, Jing-Bo Wang, Dao-Pei Lu,
David Miklos, Effie Petersdorf, Marcelo Fernandez-Vina, Stephanie J. Lee1214 Donor Lymphocyte Infusion May Reduce the Incidence of
Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation
Ulrica Forsl€ow, Jonas Mattsson, Thomas Gustafsson, Mats Remberger1222 Influence of GST Gene Polymorphisms on the Clearance of
Intravenous Busulfan in Adult Patients Undergoing Hematopoietic
Cell Transplantation
Sung-Doo Kim, Je-Hwan Lee, Eun-Hye Hur, Jung-Hee Lee, Dae-Young Kim,
Sung-Nam Lim, Yunsuk Choi, Hyeong-Seok Lim, Kyun-Seop Bae, Gyu-Jeong Noh,
Sung-Cheol Yun, Sang Beom Han, Kyoo-Hyung Lee1231 NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome
after Nonmyeloablative Allogeneic Stem Cell Transplantation
Hanneke M. van der Straaten, Martine M. Paquay, Marcel G. J. Tilanus,
Nan van Geloven, Leo F. Verdonck, Cynthia HuismanContinued
Contents, continued1237 ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched
Unrelated Donor Hematopoietic Cell Transplantation
Joseph Pidala, Marcie Tomblyn, Taiga Nishihori, Ernesto Ayala, Teresa Field,
Hugo Fernandez, Lia Perez, Fred Locke, Melissa Alsina, Jose Leonel Ochoa,
Janelle Perkins, Cheryl Tate, Jamie Shapiro, Michelle Conwell, Ryan Bookout,
Claudio Anasetti1245 Allogeneic Hematopoietic Stem Cell Transplantation in Leukocyte
Adhesion Deficiency Type 1: A Single Center Experience
Hasan Al-Dhekri, Hamoud Al-Mousa, Mouhab Ayas, Saleh Al-Muhsen,
Abdulaziz Al-Ghonaium, Ghanam Al-Ghanam, Bandar Al-Saud,
Rand Arnaout, Amal Al-Seraihy, Ali Al-Ahmari, Abdullah Al-Jefri,
Mohammed Al-Mahr, Hassan El-SolhBRIEF ARTICLES
1250 Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly
Patients: Results of a Treatment Algorithm Employing Allogeneic
Stem Cell Transplantation with Moderately Reduced
Conditioning Intensity
Sascha Dietrich, Mindaugas Andrulis, Ute Hegenbart, Thomas Schmitt,
Frauke Bellos, Uwe M. Martens, Julia Meissner, Alwin Kr€amer, Anthony D. Ho,
Peter Dreger1255 Pharmacological Immunosuppression Reduces But Does Not
Eliminate the Need for Total-Body Irradiation in Nonmyeloablative
Conditioning Regimens for Hematopoietic Cell Transplantation
Marco Mielcarek, Beverly Torok-Storb, Rainer StorbLETTERS TO THE EDITOR
1261 Outcomes of Patients Treated and One Human Leukocyte
Antigen–Mismatched Related Compared with Matched
Unrelated Donors
Stefan O. Ciurea and Richard E. Champlin1262 Planning and Response to Radiation Exposures
Daniel Weisdorf, David Weinstock, Cullen Case, Nelson Chao, Dennis L. ConferASBMT NEWS
1264 ASBMT News
